Following stratification according to IPSS-R, a continuous decline in the AMC with rising IPSS-R categories was noted from a median of 0.30 × 10 9 /L in very low-risk patients to a median of 0.12 × 10 9 /L in very high-risk patients, with the differences between the single IPSS-R groups being highly significant (see Figure 1 and Table 2 ). 3.4.
← all excerpts
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
1
—
—